Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume -, Issue -, Pages 2102799
Publisher
Wiley
Online
2022-04-09
DOI
10.1002/adhm.202102799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy
- (2021) Minjun Xu et al. Nature Communications
- Ferroptosis Suppressor Protein 1 (FSP1) and Coenzyme Q10 Cooperatively Suppress Ferroptosis
- (2020) Kamyar Hadian BIOCHEMISTRY
- The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved!
- (2020) Massimo M. Santoro Cell Metabolism
- SnapShot: Ferroptosis
- (2020) Kamyar Hadian et al. CELL
- Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/ β ‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy
- (2020) Zhuofei Bi et al. Advanced Science
- The Metabolic Underpinnings of Ferroptosis
- (2020) Jiashuo Zheng et al. Cell Metabolism
- Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis
- (2019) Shuangquan Gou et al. BIOMATERIALS
- A new checkpoint against ferroptosis
- (2019) Deguang Liang et al. CELL RESEARCH
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
- (2019) Kirill Bersuker et al. NATURE
- The impact of oncogenic RAS on redox balance and implications for cancer development
- (2019) Jonathan K. M. Lim et al. Cell Death & Disease
- Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma
- (2018) Jing Meng et al. CANCER RESEARCH
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
- (2018) Yun Xia et al. CELL
- The Biomedical Use of Silk: Past, Present, Future
- (2018) Chris Holland et al. Advanced Healthcare Materials
- Statins attenuate outgrowth of breast cancer metastases
- (2018) Colin H. Beckwitt et al. BRITISH JOURNAL OF CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
- (2015) Vikas Jain et al. Current Drug Delivery
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
- (2014) Vladimir P. Torchilin NATURE REVIEWS DRUG DISCOVERY
- Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
- (2013) V. Nogueira et al. CLINICAL CANCER RESEARCH
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients
- (2012) Shu Zhao et al. MEDICAL ONCOLOGY
- NCATS launches drug repurposing program
- (2012) Malorye Allison NATURE BIOTECHNOLOGY
- Controlling silk fibroin particle features for drug delivery
- (2010) Andreas S. Lammel et al. BIOMATERIALS
- Treatment of triple negative breast cancer (TNBC): current options and future perspectives
- (2010) M. De Laurentiis et al. CANCER TREATMENT REVIEWS
- Silk fibroin as a vehicle for drug delivery applications
- (2010) Esther Wenk et al. JOURNAL OF CONTROLLED RELEASE
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- Degradation pathways of crystal violet by Fenton and Fenton-like systems: Condition optimization and intermediate separation and identification
- (2009) Huan-Jung Fan et al. JOURNAL OF HAZARDOUS MATERIALS
- Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion
- (2008) Olivia Fromigué et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started